233 related articles for article (PubMed ID: 18298463)
41. Matrix metalloproteinase-3 promotes early blood-spinal cord barrier disruption and hemorrhage and impairs long-term neurological recovery after spinal cord injury.
Lee JY; Choi HY; Ahn HJ; Ju BG; Yune TY
Am J Pathol; 2014 Nov; 184(11):2985-3000. PubMed ID: 25325922
[TBL] [Abstract][Full Text] [Related]
42. Combination of dexamethasone and etanercept reduces secondary damage in experimental spinal cord trauma.
Genovese T; Mazzon E; Crisafulli C; Esposito E; Di Paola R; Muià C; Di Bella P; Meli R; Bramanti P; Cuzzocrea S
Neuroscience; 2007 Nov; 150(1):168-81. PubMed ID: 17945432
[TBL] [Abstract][Full Text] [Related]
43. Matrix metalloproteinases in acute inflammation: induction of MMP-3 and MMP-9 in fibroblasts and epithelial cells following exposure to pro-inflammatory mediators in vitro.
Warner RL; Bhagavathula N; Nerusu KC; Lateef H; Younkin E; Johnson KJ; Varani J
Exp Mol Pathol; 2004 Jun; 76(3):189-95. PubMed ID: 15126100
[TBL] [Abstract][Full Text] [Related]
44. Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis.
Dang AB; Tay BK; Kim HT; Nauth A; Alfonso-Jaume MA; Lovett DH
Spine (Phila Pa 1976); 2008 Aug; 33(17):E576-9. PubMed ID: 18670324
[TBL] [Abstract][Full Text] [Related]
45. Effect of glycosaminoglycans on matrix metalloproteinases in type II collagen-induced experimental arthritis.
Sandya S; Sudhakaran PR
Exp Biol Med (Maywood); 2007 May; 232(5):629-37. PubMed ID: 17463159
[TBL] [Abstract][Full Text] [Related]
46. Modulation of inflammatory response after spinal cord trauma with deferoxamine, an iron chelator.
Paterniti I; Mazzon E; Emanuela E; Paola RD; Galuppo M; Bramanti P; Cuzzocrea S
Free Radic Res; 2010 Jun; 44(6):694-709. PubMed ID: 20370565
[TBL] [Abstract][Full Text] [Related]
47. Effect of cyclopentanone prostaglandin 15-deoxy-delta12,14PGJ2 on early functional recovery from experimental spinal cord injury.
Genovese T; Esposito E; Mazzon E; Di Paola R; Muià C; Meli R; Bramanti P; Cuzzocrea S
Shock; 2008 Aug; 30(2):142-52. PubMed ID: 18628687
[TBL] [Abstract][Full Text] [Related]
48. Poly(ADP-ribose) glycohydrolase activity mediates post-traumatic inflammatory reaction after experimental spinal cord trauma.
Cuzzocrea S; Genovese T; Mazzon E; Crisafulli C; Min W; Di Paola R; Muià C; Li JH; Esposito E; Bramanti P; Xu W; Massuda E; Zhang J; Wang ZQ
J Pharmacol Exp Ther; 2006 Oct; 319(1):127-38. PubMed ID: 16825529
[TBL] [Abstract][Full Text] [Related]
49. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events.
Noble LJ; Donovan F; Igarashi T; Goussev S; Werb Z
J Neurosci; 2002 Sep; 22(17):7526-35. PubMed ID: 12196576
[TBL] [Abstract][Full Text] [Related]
50. Erythropoietin improves oxidative stress following spinal cord trauma in rats.
Yazihan N; Uzuner K; Salman B; Vural M; Koken T; Arslantas A
Injury; 2008 Dec; 39(12):1408-13. PubMed ID: 18635178
[TBL] [Abstract][Full Text] [Related]
51. In vitro and in vivo inhibition of skin matrix metalloproteinases by Pothomorphe umbellata root extract.
Ropke CD; da Silva VV; Kera CZ; Miranda DV; de Almeida RL; Sawada TC; Barros SB
Photochem Photobiol; 2006; 82(2):439-42. PubMed ID: 16613496
[TBL] [Abstract][Full Text] [Related]
52. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
53. The matrix metalloproteinases inhibitor Ro 28-2653 [correction of Ro 26-2853] extends survival in transgenic ALS mice.
Lorenzl S; Narr S; Angele B; Krell HW; Gregorio J; Kiaei M; Pfister HW; Beal MF
Exp Neurol; 2006 Jul; 200(1):166-71. PubMed ID: 16516196
[TBL] [Abstract][Full Text] [Related]
54. Morin regulates the expression of NF-kappaB-p65, COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma.
Sivaramakrishnan V; Niranjali Devaraj S
Chem Biol Interact; 2009 Aug; 180(3):353-9. PubMed ID: 19539802
[TBL] [Abstract][Full Text] [Related]
55. Activation of cartilage matrix metalloproteinases by activated protein C.
Jackson MT; Smith MM; Smith SM; Jackson CJ; Xue M; Little CB
Arthritis Rheum; 2009 Mar; 60(3):780-91. PubMed ID: 19248107
[TBL] [Abstract][Full Text] [Related]
56. Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta.
Fang XQ; Fang M; Fan SW; Gu CL
Chin Med J (Engl); 2009 Jul; 122(14):1631-5. PubMed ID: 19719963
[TBL] [Abstract][Full Text] [Related]
57. Effect of hormones on matrix metalloproteinases gene regulation in human aortic smooth muscle cells.
Grandas OH; Mountain DJ; Kirkpatrick SS; Rudrapatna VS; Cassada DC; Stevens SL; Freeman MB; Goldman MH
J Surg Res; 2008 Jul; 148(1):94-9. PubMed ID: 18570937
[TBL] [Abstract][Full Text] [Related]
58. Induction of matrix metalloproteinase-9 and -3 in nonsteroidal anti-inflammatory drug-induced acute gastric ulcers in mice: regulation by melatonin.
Ganguly K; Swarnakar S
J Pineal Res; 2009 Aug; 47(1):43-55. PubMed ID: 19522738
[TBL] [Abstract][Full Text] [Related]
59. Microvascular protective role of pericytes in melatonin-treated spinal cord injury in the C57BL/6 mice.
Jing Y; Wu Q; Yuan X; Li B; Liu M; Zhang X; Liu S; Li H; Xiu R
Chin Med J (Engl); 2014; 127(15):2808-13. PubMed ID: 25146619
[TBL] [Abstract][Full Text] [Related]
60. Teupolioside, a phenylpropanoid glycosides of Ajuga reptans, biotechnologically produced by IRBN22 plant cell line, exerts beneficial effects on a rodent model of colitis.
Di Paola R; Esposito E; Mazzon E; Riccardi L; Caminiti R; Dal Toso R; Pressi G; Cuzzocrea S
Biochem Pharmacol; 2009 Mar; 77(5):845-57. PubMed ID: 19070602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
